Session Time: 6:00pm-7:00pm
Presentation Time: 6:00pm-7:00pm
Location: Hall D1
The importance of increasing the number of regulatory T cells (Treg) relative to T effectors for the promotion of long-term experimental allograft survival/tolerance is well-established. To achieve successful translation of Treg therapy to human organ transplantation, it is essential to generate large quantities of Treg ex vivo. IL-33 has been proven to control alloimmunity and promote graft survival by increasing endogenous Treg in rodent models. It also selectively expands mouse Treg expressing the IL-33 receptor ST2 when added to Treg/allogeneic DC cultures. We attempted to translate these rodent findings to expansion of human Treg and to determine whether IL-33 could enhance the ability of allogeneic DCs (allo-DCs) to stimulate expansion of flow-sorted Treg.
Materials & Methods:
Peripheral blood immunobead-isolated CD14+ cells were cultured with GM-CSF and IL-4 for 7 days to generate mono-DC. Irradiated DCs or anti-CD3/28 beads were co-cultured with flow-sorted peripheral blood CD4+CD25+CD127– Treg with or without 50ng/ml IL-33 for 12 days in the presence of IL-2. Anti-CD3 Ab-loaded L cells were used to stimulate 2nd round Treg expansion, with or without IL-33 in the presence of IL-2 for an additional 7 days. DCs were incubated with or without IL-33 or IL-33 plus IL-2 for 18 hours for phenotypic analysis. Proliferation of autologous Teff in the presence or absence of the expanded Treg was used to test Treg suppressive function. Expanded allorective Treg were stimulated with anti-CD3/28 beads for 3 days to assess cytokine production.
Treg stimulated by DCs in the presence of IL-33 were expanded approx 40% more in the 1st round and 50% more in the 2nd round than in the absence of IL-33. However, such differences were not observed when Treg were stimulated by anti-CD3/28 beads. Allo-DC increased expression of CD86 when co-cultured with IL-2 and IL-33, suggesting stronger stimulatory potency. Interestingly, while IL-33 cultured Treg expressed lower Helios, modestly downregulated Foxp3, and increased IFN-g and IL-17 production relative to control allo-DC Treg, they retained potent ability to suppress Teff proliferation.
IL-33 enhances DC-induced expansion of human Tregs exhibiting strong suppressive capacity, but enhanced IL-17 and IFN-g production.
CITATION INFORMATION: Zhao Y, Zhang H, Mathews L, Turnquist H, Thomson A. IL-33 Enhances the Ability of Dendritic Cells to Expand Human Regulatory T Cells. Am J Transplant. 2017;17 (suppl 3).
To cite this abstract in AMA style:Zhao Y, Zhang H, Mathews L, Turnquist H, Thomson A. IL-33 Enhances the Ability of Dendritic Cells to Expand Human Regulatory T Cells. [abstract]. Am J Transplant. 2017; 17 (suppl 3). https://atcmeetingabstracts.com/abstract/il-33-enhances-the-ability-of-dendritic-cells-to-expand-human-regulatory-t-cells/. Accessed November 24, 2020.
« Back to 2017 American Transplant Congress